MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-HR-05-0041645
Adirex Pharmaceuticals Private Limited - pharma in Gurugram, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.41 Cr
▲ 42% YoY
Net profit · FY 2025
₹48.58 Lakh
Net margin 4.7%
EBITDA · FY 2025
₹83.2 Lakh
EBITDA margin 8%
Authorised capital
₹40 Lakh
Registered with MCA
Paid-up capital
₹40 Lakh
Issued & subscribed
Open charges
₹1.81 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
25
Provident fund records
About Adirex Pharmaceuticals Private Limited
Data last updated:
Adirex Pharmaceuticals Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 October 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900HR2015PTC056936. Its GSTIN is 19AANCA8957C1Z8 (West Bengal).
The company has an authorised share capital of ₹40 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Rekha Dandapat and Debkumar Dandapat.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 77A/5 Phase – 5 Gurugram, Haryana, India – 122016.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.41 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net profit of ₹48.58 Lakh (net margin 4.7%) and EBITDA of ₹83.2 Lakh (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 36% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Adirex Pharma. As per MCA filings, the company has open charges of ₹1.81 Cr on record. The company has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019.
Adirex Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-05-0041645). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website adirexpharma.com.
Company details
CIN U74900HR2015PTC056936
Registration Number 056936
Incorporation Date 12 October 2015
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HR-05-0041645
Recognitions & Rankings of Adirex Pharmaceuticals
Contact details
Adirex Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its website is adirexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address77A/5 Phase – 5 Gurugram, Haryana, India – 122016
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Adirex Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Adirex Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Adirex Pharmaceuticals operates one associated brand: Adirex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Adirex Pharma focuses on pharmaceuticals for general health, dermatology, and pediatrics. | adirexpharma.com |
Business activity
The main business activity of Adirex Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adirex Pharmaceuticals Private Limited, buy the company report.
Financials of Adirex Pharmaceuticals Private Limited
FY 2025 filings availableAdirex Pharmaceuticals Private Limited reported revenue of ₹10.41 Cr (up 42% YoY) for FY 2025.
Revenue · FY 2025
₹10.41 Cr ▲ 42%
Net profit · FY 2025
₹48.58 Lakh margin 4.7%
EBITDA · FY 2025
₹83.2 Lakh margin 8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 10%
5 years · compounded
▲ 36%
EBITDA CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 21%
5 years · compounded
▲ 40%
Revenue has grown at a compounded annual rate (CAGR) of 36% over five years, including 42% growth in the latest year. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹83.2 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹48.58 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adirex Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adirex Pharmaceuticals Private Limited
Adirex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rekha Dandapat Also directs: Adirex Green Private Limited, Adirex Infra Private Limited | Director | 12 Oct 2015 | 11 Years 0 Months | Current |
| Debkumar Dandapat | Director | 10 Sep 2018 | 8 Years 1 Months | Current |
Auditor
Adirex Pharmaceuticals Private Limited is audited by M.P & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.P & ASSOCIATES | FY 2023 | 509883 |
Shareholding
The shareholding of Adirex Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adirex Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.81 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Oct 2024 | 101004670 | Uco Bank | ₹13 Lakh | Open | |
| 18 Oct 2022 | 100619414 | Uco Bank | ₹1.5 Cr | Open | |
| 23 Nov 2020 | 100419907 | Others | ₹18 Lakh | Open |
Total charge records: 3 View all charges
Deals & funding
Adirex Pharmaceuticals Private Limited has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019.
Total deals
3
Secondary share transfers
2
Rights issue
1
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2018 | Rights issue | ₹39 Lakh | Investors: 4 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Adirex Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adirex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Adirex Pharmaceuticals Private Limited has a workforce of 25 employees on its EPFO records as of Apr 07, 2024, across 1 active EPFO establishment.
Employee count
25
Active EPFO establishments
1
Employee growth
31.58%
GST
Adirex Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AANCA8957C1Z8 | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Adirex Pharmaceuticals Private Limited, buy the company report.
Recent activity
Adirex Pharmaceuticals Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Debkumar Dandapat was appointed as Director on 10 Sep 2018.
AGM
Adirex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Adirex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Uco Bank amounted to Rs. 13.00 Lakh with Charge ID 101004670 was registered on 28 Oct 2024.
Charges
A charge with Uco Bank amounted to Rs. 150.00 Lakh with Charge ID 100619414 was registered on 18 Oct 2022.
Charges
A charge with Others amounted to Rs. 18.00 Lakh with Charge ID 100419907 was registered on 23 Nov 2020.
Appointed
Debkumar Dandapat was appointed as Director.
Ceased
Monali Datta ceased to be Director.
Ceased
Sirin Sekh ceased to be Director.
Appointed
Rekha Dandapat was appointed as Director.
Incorporation
12 Oct 2015
Adirex Pharmaceuticals Private Limited was registered on 12 Oct 2015 with Roc Delhi & aged 11 years 27 days as per MCA records.
Frequently asked questions
Adirex Pharmaceuticals is an active private limited company based in Gurugram, Haryana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 October 2015 (11+ years old) and is registered under CIN U74900HR2015PTC056936.
Adirex Pharmaceuticals has 2 current directors:
- Rekha Dandapat - Director
- Debkumar Dandapat - Director
The latest financial statements of Adirex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Adirex Pharmaceuticals is 19AANCA8957C1Z8, registered in West Bengal.
The CIN (Corporate Identification Number) of Adirex Pharmaceuticals is U74900HR2015PTC056936. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adirex Pharmaceuticals was incorporated on 12 October 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
Adirex Pharmaceuticals has 3 deals on record (2 secondary share transfers, 1 rights issue); the latest was in March 2019.
Debkumar Dandapat was appointed as Director on 10 Sep 2018. Monali Datta ceased to be Director on 10 Sep 2018. Sirin Sekh ceased to be Director on 10 Sep 2018. Adirex Pharmaceuticals has 4 board changes on record in total.
Yes, Adirex Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HR-05-0041645).
Adirex Pharmaceuticals can be reached through the website adirexpharma.com. Its registered office is in Gurugram, Haryana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages